BIOLINE RX revenue breakdown overview

BIOLINE RX revenue for the last year amounted to 105.45 M ILS, the most of which — 84.83 M ILS — came from its highest performing source at the moment, Oncology and Hematology, the year earlier bringing 700.72 k ILS. The greatest contribution to the revenue figure was made by China — last year it brought BIOLINE RX 55.37 M ILS.